Isuzinaxib hydrochloride
Tier C — Watch / tradeIsuzinaxib hydrochloride
Targets：NOX
Indications (approved)：Diabetic nephropathy, 急性肾损伤, COVID-19, Type 2 diabetes
Regional status
Synthetic routes & intermediates1 routes
Routes are ordered originator first, then optimised / process (non-patent) routes; each lists steps, overall yield and the intermediate table (code / CAS / name) — ready for supplier sourcing and RFQ. Rendered by this site from structured data; no third-party route graphics used.
| Code | CAS No. | Intermediate |
|---|---|---|
| APX-115 | 1270084-92-8 | - |
| APX-115-001 | 24317-96-2 | ethyl 2-benzoylpentanoate |
| APX-115-002 | 4930-98-7 | 2-hydrazineylpyridine |
Frequently asked questions
What are the approved indications of Isuzinaxib hydrochloride?
Approved indications include: Diabetic nephropathy, 急性肾损伤, COVID-19, Type 2 diabetes.
When does the Isuzinaxib hydrochloride patent expire?
No public expiry year is available for Isuzinaxib hydrochloride yet; this page updates once verified.
How many synthesis routes are recorded for Isuzinaxib hydrochloride?
1 synthesis routes are recorded; the shortest is 1 steps with / total yield. Intermediates in each route carry codes and CAS numbers.
Where can I buy Isuzinaxib hydrochloride intermediates?
All intermediates in Isuzinaxib hydrochloride routes have CAS profiles — you can submit an RFQ per CAS and it enters the Unibest matching pool.
How do I get a quote for Isuzinaxib hydrochloride intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-10-06